Skip to main content
Clinical Trials/NCT07014618
NCT07014618RecruitingNot Applicable

Impact of Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

University of Oklahoma1 site in 1 country420 target enrollmentStarted: October 16, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
420
Locations
1
Primary Endpoint
Number of Patients Who Complete Radiation Therapy

Study Overview

Brief Summary

The purpose of this clinical trial is to evaluate radiation therapy (RT) completion rates among underrepresented cancer populations using qualitative measurements. Additionally, the study aims to assess the impact of patient navigators on supporting patients through their radiation care, as well as their influence on adherence to standard of care treatment modalities.

Detailed Description

The study aims to utilize qualitative measurements, including pre- and post-treatment breast and prostate cancer surveys tailored to specific ethnic groups-Native American, African American, and Hispanic/Latino populations. In addition to these culturally relevant surveys, participants will also complete the COST-Functional Assessment of Chronic Illness Therapy (COST-FACT) score to evaluate the financial and functional impact of their cancer care experience.

Those who choose to complete the surveys will be offered navigation assistance as part of the study intervention.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subjects must have histologically or cytologically confirmed Breast or Prostate Cancer.
  • Subjects must be 18 years of age or older. This study requires informed consent by the subject.
  • Subjects must be of African American race, Native American race, or Hispanic ethnicity.
  • Subjects scheduled to undergo RT for Cancer Treatment.
  • Subjects must have the ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria

  • Subjects NOT of African American race, Native American race or Hispanic ethnicity.
  • Subjects WITHOUT histologically/cytologically confirmed Breast or Prostate Cancer.
  • Subjects younger than 18 years old.

Outcomes

Primary Outcomes

Number of Patients Who Complete Radiation Therapy

Time Frame: 6 months

Survey-based methods will be used to assess barriers facing under-represented minority cancer patient access to patient navigation. This study will use a patient-completed, culturally sensitive survey adapted from "Walking Forward," a patient navigator program providing culturally appropriate community education on cancer, screening and treatment, to include barriers to specific RT regimens, and concerns regarding transportation.

Secondary Outcomes

  • Number of Patients Successfully Impacted by Patient Navigation on Radiation Therapy(6 Months)
  • Investigate The Differences in Financial Toxicity Levels(6 Months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials